Vusolimogene Oderparepvec Secures Approval for Advanced Melanoma
Regulators have approved vusolimogene oderparepvec for advanced melanoma, adding an oncolytic viral therapy to the systemic options for a disease where many patients still progress on checkpoint inhi…